Cambridge Investment Research Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-893	Closed	-$250K	–	3832
2025 Q3	$250K	Sell	893 -196	-18%	-$53.3K	﹤0.01%	3285
2025 Q2	$263K	Buy	1,089 +56	+5%	+$13.2K	﹤0.01%	3088
2025 Q1	$252K	Buy	1,033 +209	+25%	+$62.9K	﹤0.01%	3014
2024 Q4	$271K	Buy	+824	New	+$280K	﹤0.01%	2915
2024 Q2	–	Sell	-4,798	Closed	-$1.66M	–	3324
2024 Q1	$1.66M	Buy	4,798 +4,139	+628%	+$1.36M	0.01%	1389
2023 Q4	$213K	Sell	659 -33	-5%	-$10.3K	﹤0.01%	2849
2023 Q3	$248K	Sell	692 -40	-5%	-$15.4K	﹤0.01%	2650
2023 Q2	$278K	Sell	732 -167	-19%	-$68K	﹤0.01%	2596
2023 Q1	$431K	Sell	899 -50	-5%	-$23.4K	﹤0.01%	2193
2022 Q4	$399K	Buy	949 +141	+17%	+$56.9K	﹤0.01%	2200
2022 Q3	$337K	Sell	808 -140	-15%	-$69.8K	﹤0.01%	2270
2022 Q2	$469K	Sell	948 -95	-9%	-$49.5K	﹤0.01%	2009
2022 Q1	$587K	Sell	1,043 -259	-20%	-$156K	﹤0.01%	1974
2021 Q4	$984K	Sell	1,302 -336	-21%	-$251K	﹤0.01%	1590
2021 Q3	$1.22M	Buy	1,638 +201	+14%	+$151K	0.01%	1382
2021 Q2	$926K	Buy	1,437 +337	+31%	+$205K	﹤0.01%	1582
2021 Q1	$628K	Buy	1,100 +350	+47%	+$207K	﹤0.01%	1726
2020 Q4	$437K	Buy	750 +273	+57%	+$155K	﹤0.01%	1859
2020 Q3	$246K	Buy	+477	New	+$242K	﹤0.01%	2084